Xiaoyu Qi

506 total citations
18 papers, 387 citations indexed

About

Xiaoyu Qi is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Xiaoyu Qi has authored 18 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Xiaoyu Qi's work include Viral-associated cancers and disorders (5 papers), interferon and immune responses (3 papers) and RNA modifications and cancer (3 papers). Xiaoyu Qi is often cited by papers focused on Viral-associated cancers and disorders (5 papers), interferon and immune responses (3 papers) and RNA modifications and cancer (3 papers). Xiaoyu Qi collaborates with scholars based in China and United States. Xiaoyu Qi's co-authors include Shujuan Shao, Shuguo Zheng, Huanhuan Jin, Anping Song, Chunfeng Lu, Zhaoyuan Hou, Lan Wang, Linlin Gong, Yang Song and Lu Liu and has published in prestigious journals such as PLoS ONE, Oncogene and Cell Death and Differentiation.

In The Last Decade

Xiaoyu Qi

17 papers receiving 385 citations

Peers

Xiaoyu Qi
Comparison fields: 5 of 70
  • Molecular Biology 235
  • Cancer Research 138
  • Oncology 92
  • Epidemiology 84
  • Pulmonary and Respiratory Medicine 70
Replace Yaqiu Zheng with:
Yaqiu Zheng China
Víctor H. Villar Spain
Ying Song China
Xinyuan Ding China
Qiuju Fan China
Zhenkun Xia China
Harilaos Filippakis United States
Baojia Zou China
Zhenqing Sun China
Ashley Eheim Germany
Yaqiu Zheng China View profile →
Citations per field, relative to Xiaoyu Qi
Xiaoyu Qi · 1×
Citations per year, relative to Xiaoyu Qi
Xiaoyu Qi · 1×

Countries citing papers authored by Xiaoyu Qi

Since Specialization
Citations

This map shows the geographic impact of Xiaoyu Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyu Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyu Qi more than expected).

Fields of papers citing papers by Xiaoyu Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyu Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyu Qi. The network helps show where Xiaoyu Qi may publish in the future.

Co-authorship network of co-authors of Xiaoyu Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyu Qi. A scholar is included among the top collaborators of Xiaoyu Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyu Qi. Xiaoyu Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
# Work Indexed citations
1 5
2 0
3 2
4 3
5 11
6 43
7 15
8 26
9 62
10 25
11 13
12 12
13 14
14 10
15 39
16
[Effect of HBXIP on biological function and PI3K/Akt signaling pathway of adenoid cystic carcinoma cell line ACC-M].
2
17 102
18 3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026